GlassScriptPhysician profile
Amir Arsalan
NPI 1629463229
$3,266.38
in general payments reported to CMS, 2019-2025
9 companies · $1,263 in 2025
The $1,263 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $830 · 2023: $409 · 2024: $592 · 2025: $1,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816 · Travel and Lodging: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,815.81 |
| Travel and Lodging | $447.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $970.56 | 2021-2022 | |
| Motiva USA, LLC | $939.78 | 2025 | |
| Abbvie INC. | $689.73 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Mentor Worldwide LLC | $266.41 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Access Pro Medical, LLC | $190.91 | 2025 | Matriderm |
| Galderma Laboratories, L.P. | $82.56 | 2022-2025 | |
| Revance Therapeutics, INC. | $70.59 | 2024-2025 | Daxxify |
| Smith+Nephew, INC. | $33.01 | 2022-2025 | Pico 7 |
| Lilly USA, LLC | $22.83 | 2025 | Taltz, Ebglyss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Arsalan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.